+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dialyzer Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797910
The global Dialyzer market value in 2022 was USD 6.2 billion driven by the growing demand for home-based dialysis treatment across the globe. The market size is anticipated to grow at a CAGR of 5.2% during the forecast period of 2023-2031 to achieve a value of USD 9.77 billion by 2031.

Dialyzer Introduction

Dialyzers are medical devices used in the treatment of patients with chronic kidney disease, end-stage renal disease, or acute kidney injury. Dialysis is the process of filtering and removing waste and excess fluid from the blood when the kidneys are unable to perform these functions. Dialyzers are an essential component of hemodialysis machines, which are used to perform this process.

The dialyzer market has experienced significant growth over the past few years, primarily due to the increasing prevalence of chronic kidney diseases, rising geriatric population, and growing demand for home-based dialysis treatment. Technological advancements, such as the development of high-performance dialyzers and the integration of software and sensors into these devices, have also contributed to market growth.

Additionally, increasing investment in research and development activities to develop more efficient and cost-effective dialysis products is expected to fuel market growth in the coming years. However, factors such as high costs associated with dialysis treatment and stringent government regulations could hamper market growth.

Overall, the dialyzer market is expected to continue growing as the prevalence of chronic kidney diseases and end-stage renal disease continues to increase globally.

Dialyzer Market Scenario

Dialyzers are an important component of the hemodialysis procedure, which is a life-saving treatment for people with end-stage renal disease. Dialyzers, also known as artificial kidneys, filter waste products and excess fluid from the blood when the patient's kidneys are unable to perform this function. Dialyzers are typically made up of a semipermeable membrane and are designed to be biocompatible with the patient's body. They are available in various sizes and configurations to meet the specific needs of patients.

The global dialyzer market is primarily driven by the rising prevalence of end-stage renal disease and the increasing number of patients requiring dialysis. The market is also being fueled by the growing adoption of home dialysis treatments and the increasing demand for high-flux dialyzers. The market is highly competitive, with several established players competing for market share. Key players in the dialyzer market are focusing on product innovation and new product development to gain a competitive advantage.

Overall, the dialyzer market is expected to experience steady growth in the coming years, driven by the rising demand for dialysis treatments and the increasing adoption of home dialysis.

Dialyzer Market Segmentations

Market Breakup by Flux Type

  • High Flux
  • Low Flux
  • Others

Market Breakup by Usage

  • Disposable
  • Reusable

Market Breakup by End User

  • In Centre Dialysis
  • Hospital Dialysis
  • Home Dialysis
  • Independent Dialysis
  • Peritoneal Dialysis
  • Home Haemodialysis

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Dialyzer Market

The key trends in the dialyzer market are:
  • Increasing prevalence of end-stage renal disease (ESRD) and chronic kidney diseases (CKD) worldwide
  • Growing geriatric population and rising incidence of diabetes and hypertension, which are the major causes of kidney failure
  • Technological advancements in dialyzer technology, such as high-flux dialyzers, online hemodiafiltration, and improved biocompatibility, leading to better patient outcomes and increased adoption
  • Increasing demand for home hemodialysis (HHD) and peritoneal dialysis (PD) due to convenience and lower cost compared to in-center hemodialysis
  • Growing demand for reuse of dialyzers due to cost-effectiveness and environmental concerns
  • Increasing preference for high-quality, high-performance dialyzers to improve patient outcomes and reduce the risk of infections
  • Rising demand for portable and compact dialyzers, especially in emerging markets, to cater to the needs of patients in remote locations with limited access to healthcare facilities
  • Consolidation of the market through mergers and acquisitions, with leading players focusing on expanding their product portfolios and global footprint

Dialyzer Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Baxter International, Inc
  • Nipro Corporation
  • Nikkiso Co., Ltd
  • Asahi Kasei Medical Co., Ltd
  • JMS Co., Ltd
  • B. BRAUN MELSUNGEN AG
  • BROWNDOVE HEALTHCARE (P) LTD
  • BAIN MEDICAL EQUIPMENT
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • KAWASUMI LABORATORIES INC
  • MEDTRONIC PLC. (BELCO)
  • JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
  • ALLMED MEDICAL CARE HOLDINGS LIMITED
  • WEIGAO GROUP
  • CHINA CHENGDU WESLEY BIOTECH CO., LTD
  • MEDICA GROUP
  • TORAY INDUSTRIES, INC
  • MEDIVATORS, INC.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Dialyzer Market Overview
3.1 Global Dialyzer Market Historical Value (2016-2022)
3.2 Global Dialyzer Market Forecast Value (2023-2031)
4 Global Dialyzer Market Landscape
4.1 Global Dialyzer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Dialyzer Product Landscape
4.2.1 Analysis by Flux Type
4.2.2 Analysis by Uses
4.2.3 Analysis by End User
5 Global Dialyzer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Dialyzer Market Segmentation
6.1 Global Dialyzer Market by Flux Type
6.1.1 Market Overview
6.1.2 High Flux
6.1.3 Low Flux
6.1.4 Others
6.2 Global Dialyzer Market by Usage
6.2.1 Market Overview
6.2.2 Disposable
6.2.3 Reusable
6.3 Global Dialyzer Market by End User
6.3.1 Market Overview
6.3.2 In Centre Dialysis
6.3.3 Hospital Dialysis
6.3.4 Home Dialysis
6.3.5 Independent Dialysis
6.3.6 Peritoneal Dialysis
6.3.7 Home Haemodialysis
6.4 Global Dialyzer Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Dialyzer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Dialyzer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Dialyzer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Dialyzer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Dialyzer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Baxter International, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Nipro Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Nikkiso Co., Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Asahi Kasei Medical Co., Ltd.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 JMS Co., Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. BRAUN MELSUNGEN AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BROWNDOVE HEALTHCARE (P) LTD.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 BAIN MEDICAL EQUIPMENT
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 FRESENIUS MEDICAL CARE AG & CO. KGAA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 KAWASUMI LABORATORIES INC.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 MEDTRONIC PLC. (BELCO)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 ALLMED MEDICAL CARE HOLDINGS LIMITED
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 WEIGAO GROUP
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 CHINA CHENGDU WESLEY BIOTECH CO., LTD
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 MEDICA GROUP
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 TORAY INDUSTRIES, INC.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 MEDIVATORS, INC.
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
18 Global Dialyzer Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Baxter International, Inc.
  • Nipro Corporation
  • Nikkiso Co. Ltd.
  • Asahi Kasei Medical Co. Ltd.
  • Jms Co. Ltd.
  • B. Braun Melsungen AG
  • Browndove Healthcare (P) Ltd.
  • Bain Medical Equipment
  • Fresenius Medical Care AG & Co. Kgaa
  • Kawasumi Laboratories Inc.
  • Medtronic plc. (Belco)
  • Jihua Medical Apparatus & Instruments Co. Ltd
  • Allmed Medical Care Holdings Limited
  • Weigao Group
  • China Chengdu Wesley Biotech Co. Ltd
  • Medica Group
  • Toray Industries, Inc.
  • Medivators, Inc.

Methodology

Loading
LOADING...

Table Information